Pulmonx Corporation
NASDAQ:LUNG
8.31 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Pulmonx Corporation |
Symbool | LUNG |
Munteenheid | USD |
Prijs | 8.31 |
Beurswaarde | 325,358,106 |
Dividendpercentage | 0% |
52-weken bereik | 5.46 - 14.835 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Glendon E. French |
Website | https://pulmonx.com |
An error occurred while fetching data.
Over Pulmonx Corporation
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)